• Multimodal AGuIX® Nanoparticles: Size Characterization by HF5 and Optimization of the Radiolabeling with Various SPECT/PET/Theranostic Tracers, Huclier-Markai S, Ntsiba E, Thomas E, Alliot C, Cutler CS, et al., Int J Med Nano, 2019, Res 6:027

  • Equilibrium, affinity, dissociation constants, IC5O: Facts and fantasies, Barbet J, Huclier‐Markai S, Pharmaceutical Statistics. oct 2019;18(5):513‑25.

  • Azacalixquinarenes: From Canonical to (Poly-)Zwitterionic Macrocycles, Pascal S, Lavaud L, Azarias C, Varlot A, Canard G, Giorgi M, et al., J Org Chem. févr 2019;84(3):1387‑97.

  • Advances in the Radiolabeling of Antibodies with Astatine-211: Toward Simplified Procedures and Improved Radiochemical Yields, Guérard F, Navarro L, Berdal M, Haddad F, Chérel M, Gestin J-F, Journal of Medical Imaging and Radiation Sciences. déc 2019;50(4):S99‑100.

  • Quantum calculations of At-mediated halogen bonds: on the influence of relativistic effects, N.Galland, G. Montavon, J.-Y. Le Questel, J. Graton, New J. Chem., 42, 10510-10517 (2018)

  • Experimental and computational evidence of halogen bonds involving astatine, N. Guo, R. Maurice, D.Teze, J. Graton, J. Champion, G. Montavon, N. Galland, Nat. Chem., 10, 428-434 (2018)